Autoimmune Disease Therapeutics Market (By Drug Class: Anti-inflammatory, Antihyperglycemics, NSAIDs, Interferons, Others; By Indication: Rheumatic Disease, Type 1 Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, Other Indications; By Sales Channel: Hospital Pharmacy, Drug Store & Retail Pharmacy, Online Store) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Autoimmune Disease Therapeutics
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Autoimmune Disease Therapeutics Market By Drug Class
     1.2.2.1. Global Autoimmune Disease Therapeutics Market Revenue and Growth Rate Comparison By Drug Class(2020-2027)
     1.2.2.2. Global Autoimmune Disease Therapeutics Market Revenue Share By Drug Class in 2019
     1.2.2.3. Anti-inflammatory
     1.2.2.4. Antihyperglycemics
     1.2.2.5. NSAIDs
     1.2.2.6. Interferons
     1.2.2.7. Others
   1.2.3. Autoimmune Disease Therapeutics Market By Indication
     1.2.3.1. Global Autoimmune Disease Therapeutics Market Revenue and Growth Rate Comparison By Indication (2020-2027)
     1.2.3.2. Global Autoimmune Disease Therapeutics Market Revenue Share By Indication in 2019
       1.2.3.2.1. Rheumatic Disease
       1.2.3.2.2. Type 1 Diabetes
       1.2.3.2.3. Multiple Sclerosis
       1.2.3.2.4. Inflammatory Bowel Disease
       1.2.3.2.5. Other Indications
   1.2.4. Autoimmune Disease Therapeutics Market By Sales Channel
     1.2.4.1. Global Autoimmune Disease Therapeutics Market Revenue and Growth Rate Comparison By Sales Channel(2020-2027)
     1.2.4.2. Global Autoimmune Disease Therapeutics Market Revenue Share By Sales Channel in 2019
       1.2.4.2.1. Hospital Pharmacy
       1.2.4.2.2. Drug Store & Retail Pharmacy
       1.2.4.2.3. Online Store
   1.2.5. Autoimmune Disease Therapeutics Market By Geography
     1.2.5.1. Global Autoimmune Disease Therapeutics Market Revenue and Growth Rate Comparison by Geography (2020-2027)
     1.2.5.2. North America Autoimmune Disease Therapeutics Market Revenue and Growth Rate(2020-2027)
     1.2.5.3. Europe Autoimmune Disease Therapeutics Market Revenue and Growth Rate(2020-2027)
     1.2.5.4. Asia-Pacific Autoimmune Disease Therapeutics Market Revenue and Growth Rate(2020-2027)
     1.2.5.5. Latin America Autoimmune Disease Therapeutics Market Revenue and Growth Rate(2020-2027)
     1.2.5.6. Middle East and Africa (MEA) Autoimmune Disease Therapeutics Market Revenue and Growth Rate(2020-2027)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING AUTOIMMUNE DISEASE THERAPEUTICS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Autoimmune Disease Therapeutics Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Autoimmune Disease Therapeutics Major Manufacturers in 2019
3.3. R&D Status and Manufacturing End-User of Global Autoimmune Disease Therapeutics Major Manufacturers in 2019
3.4. Raw Materials End-Users Analysis of Global Autoimmune Disease Therapeutics Major Manufacturers in 2019

CHAPTER 4. AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS
4.1. Global Autoimmune Disease Therapeutics Revenue By Drug Class
4.2. Anti-inflammatory
   4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.3. Antihyperglycemics
   4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.4. NSAIDs
   4.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.5. Interferons
   4.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.6. Others
   4.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 5. AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION
5.1. Global Autoimmune Disease Therapeutics Revenue By Indication
5.2. Rheumatic Disease
   5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Type 1 Diabetes
   5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.4. Multiple Sclerosis
   5.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.5. Inflammatory Bowel Disease
   5.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.6. Other Indications
   5.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 6. AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY SALES CHANNEL
6.1. Global Autoimmune Disease Therapeutics Revenue By Sales Channel
6.2. Hospital Pharmacy
   6.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.3. Drug Store & Retail Pharmacy
   6.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.4. Online Store
   6.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 7. NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY
7.1. North America Autoimmune Disease Therapeutics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.2. North America Autoimmune Disease Therapeutics Market Revenue Share Comparison, 2020 & 2027 (%)
7.3. U.S.
   7.3.1. U.S. Autoimmune Disease Therapeutics Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   7.3.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   7.3.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   7.4.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   7.4.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)

CHAPTER 8. EUROPE SMART REFRIGERATOR MARKET BY COUNTRY
8.1. Europe Autoimmune Disease Therapeutics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. Europe Autoimmune Disease Therapeutics Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   8.3.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   8.3.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   8.4.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   8.4.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   8.5.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   8.5.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   8.6.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   8.6.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   8.7.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   8.7.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)

CHAPTER 9. ASIA-PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY
9.1. Asia-Pacific Autoimmune Disease Therapeutics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Asia-Pacific Autoimmune Disease Therapeutics Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. China
     9.3.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
     9.3.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
     9.3.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
9.4. Japan
     9.4.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
     9.4.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
     9.4.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
9.5. India
     9.5.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
     9.5.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
     9.5.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
9.6. Australia
     9.6.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
     9.6.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
     9.6.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
9.7. South Korea
     9.7.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
     9.7.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
     9.7.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
9.8. Rest of Asia-Pacific
     9.8.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
     9.8.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
     9.8.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)

CHAPTER 10. LATIN AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY
10.1. Latin America Autoimmune Disease Therapeutics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Latin America Autoimmune Disease Therapeutics Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. Brazil
     10.3.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
     10.3.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
     10.3.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
10.4. Mexico
     10.4.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
     10.4.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
     10.4.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
10.5. Rest of Latin America
     10.5.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
     10.5.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
     10.5.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY
11.1. Middle East & Africa Autoimmune Disease Therapeutics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
11.2. Middle East & Africa Autoimmune Disease Therapeutics Market Revenue Share Comparison, 2020 & 2027 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   11.3.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   11.3.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   11.4.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   11.4.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)
11.5. Rest of Middle East & Africa
   11.5.1. Market Revenue and Forecast By Drug Class, 2020 - 2027 ($Million)
   11.5.2. Market Revenue and Forecast By Indication, 2020 - 2027 ($Million)
   11.5.3. Market Revenue and Forecast By Sales Channel, 2020 - 2027 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. AbbVie Inc
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Product Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Abbott Laboratories
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Product Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. Amgen Inc.
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Product Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Bristol-Myers Squibb Company
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Product Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. AstraZeneca plc.
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Product Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. F. Hoffmann-La Roche AG
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Product Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Novartis AG
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Product Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. Pfizer Inc.
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Product Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. Johnson & Johnson
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Product Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Others
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Product Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope